Data availability
The data that support the findings of this study are available from the corresponding authors Wei Ren, Sijin Yang and Zengjin Liu, upon reasonable request.
References
Fu M, Xiao Y, Qian X, Zhao D, Xu Y. A design concept of long-wavelength fluorescent analogs of rhodamine dyes: replacement of oxygen with silicon atom. Chem Commun (Camb). 2008;15:1780–2.
Ahn SH, Thach D, Vaughn BA, Alford VM, Preston AN, Laughlin ST, Boros E. Linear desferrichrome-linked silicon-rhodamine antibody conjugate enables targeted multimodal imaging of HER2 in vitro and in vivo. Mol Pharm. 2019;16(3):1412–20.
Kushida Y, Nagano T, Hanaoka K. Silicon-substituted xanthene dyes and their applications in bioimaging. Analyst. 2015;140(3):685–95.
Mao Z, Jiang H, Song X, Hu W, Liu Z. Development of a silicon-rhodamine based near-infrared emissive two-photon fluorescent probe for nitric oxide. Anal Chem. 2017;89(18):9620–4.
Frei MS, Hoess P, Lampe M, Nijmeijer B, Kueblbeck M, Ellenberg J, Wadepohl H, Ries J, Pitsch S, Reymond L, Johnsson K. Photoactivation of silicon rhodamines via a light-induced protonation. Nat Commun. 2019;10(1):4580.
Wang L, Frei MS, Salim A, Johnsson K. Small-molecule fluorescent probes for live-cell super-resolution microscopy. J Am Chem Soc. 2019;141(7):2770–81.
Chyan W, Raines RT. Enzyme-activated fluorogenic probes for live-cell and in vivo imaging. ACS Chem Biol. 2018;13(7):1810–23.
Lardon N, Wang L, Tschanz A, Hoess P, Tran M, D’Este E, Ries J, Johnsson K. Systematic tuning of rhodamine spirocyclization for super-resolution microscopy. J Am Chem Soc. 2021;143(36):14592–600.
Ortiz G, Liu P, Deal PE, Nensel AK, Martinez KN, Shamardani K, Adesnik H, Miller EW. A silicon-rhodamine chemical-genetic hybrid for far red voltage imaging from defined neurons in brain slice. RSC Chem Biol. 2021;2(6):1594–9.
Lukinavičius G, Reymond L, D’Este E, Masharina A, Göttfert F, Ta H, Güther A, Fournier M, Rizzo S, Waldmann H, Blaukopf C, Sommer C, Gerlich DW, Arndt HD, Hell SW, Johnsson K. Fluorogenic probes for live-cell imaging of the cytoskeleton. Nat Methods. 2014;11(7):731–3.
Karch S, Broichhagen J, Schneider J, Böning D, Hartmann S, Schmid B, Tripal P, Palmisano R, Alzheimer C, Johnsson K, Huth T. A new fluorogenic small-molecule labeling tool for surface diffusion analysis and advanced fluorescence imaging of β-Site amyloid precursor protein-cleaving enzyme 1 based on silicone rhodamine: SiR-BACE1. J Med Chem. 2018;61(14):6121–39.
Lukinavičius G, Blaukopf C, Pershagen E, Schena A, Reymond L, Derivery E, Gonzalez-Gaitan M, D’Este E, Hell SW, Wolfram Gerlich D, Johnsson K. SiR-Hoechst is a far-red DNA stain for live-cell nanoscopy. Nat Commun. 2015;6:8497.
Brandes B, Hoenke S, Fischer L, Csuk R. Design, synthesis and cytotoxicity of BODIPY FL labelled triterpenoids. Eur J Med Chem. 2020;185:111858.
Zhu PJ, Yu ZZ, Lv YF, Zhao JL, Tong YY, You QD, Jiang ZY. Discovery of 3,5-Dimethyl-4-Sulfonyl-1H-Pyrrole-based myeloid cell leukemia 1 inhibitors with high affinity, selectivity, and oral bioavailability. J Med Chem. 2021;64(15):11330–53.
Butkevich AN. Modular synthetic approach to silicon-rhodamine homologues and analogues via bis-aryllanthanum reagents. Org Lett. 2021;23(7):2604–9.
Matthias J, Kanagasundaram T, Kopka K, Kramer CS. Synthesis of a dihalogenated pyridinyl silicon rhodamine for mitochondrial imaging by a halogen dance rearrangement. Beilstein J Org Chem. 2019;15:2333–43.
Grimm JB, Brown TA, Tkachuk AN, Lavis LD. General synthetic method for Si-fluoresceins and Si-rhodamines. ACS Cent Sci. 2017;3(9):975–85.
Xiao Y, Qian XH. Substitution of oxygen with silicon: a big step forward for—fluorescent dyes in life science. Coord Chem Rev. 2020;423:213513.
Wang B, Chai X, Zhu W, Wang T, Wu Q. A general approach to spirolactonized Si-rhodamines. Chem Commun (Camb). 2014;50(92):14374–7.
Gao J, Hou B, Zhu Q, Yang L, Jiang X, Zou Z, Li X, Xu T, Zheng M, Chen YH, Xu Z, Xu H, Yu H. Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy. Nat Commun. 2022;13(1):4318.
Majumder R, Mandal M. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach. J Biomol Struct Dyn. 2022;40(2):696–711.
Jin Y, Fan J, Wang R, Wang X, Li N, You Q, Jiang Z. Ligation to scavenging strategy enables on-demand termination of targeted protein degradation. J Am Chem Soc. 2023;145(13):7218–29.
Dooley KE, Warburton A, McBride AA. Tandemly integrated HPV16 can form a BRD4-dependent super-enhancer-like element that drives transcription of viral oncogenes. Mbio. 2016;7(5):e01446-16.
Donati B, Lorenzini E, Ciarrocchi A. Brd4 and cancer: going beyond transcriptional regulation. Mol Cancer. 2018;17(1):164.
Wu Y, Wang Y, Diao P, Zhang W, Li J, Ge H, Song Y, Li Z, Wang D, Liu L, Jiang H, Cheng J. Therapeutic targeting of BRD4 in head neck squamous cell carcinoma. Theranostics. 2019;9(6):1777–93.
Liao X, Qian X, Zhang Z, Tao Y, Li Z, Zhang Q, Liang H, Li X, Xie Y, Zhuo R, Chen Y, Jiang Y, Cao H, Niu J, Xue C, Ni J, Pan J, Cui D. ARV-825 demonstrates antitumor activity in gastric cancer via MYC-targets and G2M-checkpoint signaling pathways. Front Oncol. 2021;11:753119.
Wu SY, Lee CF, Lai HT, Yu CT, Lee JE, Zuo H, Tsai SY, Tsai MJ, Ge K, Wan Y, Chiang CM. Opposing functions of BRD4 isoforms in breast cancer. Mol Cell. 2020;78(6):1114–1132.
Liu J, Duan Z, Guo W, Zeng L, Wu Y, Chen Y, Tai F, Wang Y, Lin Y, Zhang Q, He Y, Deng J, Stewart RL, Wang C, Lin PC, Ghaffari S, Evers BM, Liu S, Zhou MM, Zhou BP, Shi J. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. Nat Commun. 2018;9(1):5200.
Grimm JB, English BP, Chen J, Slaughter JP, Zhang Z, Revyakin A, Patel R, Macklin JJ, Normanno D, Singer RH, Lionnet T, Lavis LD. A general method to improve fluorophores for live-cell and single-molecule microscopy. Nat Methods. 2015;12(3):244–50.
He S, Dong G, Li Y, Wu S, Wang W, Sheng C. Potent dual BET/HDAC inhibitors for efficient treatment of pancreatic cancer. Angew Chem Int Ed Engl. 2020;59(8):3028–32.
Acknowledgements
This research was funded by the Sichuan Science and Technology Program ( 24NSFSC5985, 2022YFS0635), the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202207), the Luzhou Science and Technology Program (2022-SYF-38, 2020-JYJ-51), university-level project of Southwest Medical University (2021ZKQN118), Joint project of Southwest Medical University and Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University (2020XYLH-016) and the Innovation Team of Sichuan Provincial Administration of Traditional Chinese Medicine (2022C007). Thanks for the experiment conditions provided by Luzhou Key Laboratory for Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases with Integrated Traditional Chinese and Western Medicine and the High-resolution Mass Spectrometry Testing Center of the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing financial interests.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Zhou, Y., Bi, T., Wang, R. et al. Optimization of the Procedure for Gram Scale Synthesis of Silicon Rhodamine and its Application in Labeling BRD4 Kinase Inhibitor. J. Anal. Test. (2024). https://doi.org/10.1007/s41664-024-00309-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s41664-024-00309-y